Current BTA guidelines and statements

 

The following are in chronological order with the most recent first: 

 

1st December 2019

Radioiodine has been used very effectively to treat thyroid overactivity since the 1940’s, but a recent study has cast doubt on its safety, causing considerable concern. A joint position statement from the British Thyroid Association and Society for Endocrinology - here -  highlights important limitations of this study which may confound its conclusions and calls for caution in interpretation of its results

 

Switching from Liothyronine (LT-3) to Levothyroxine (LT-4)? - 2016

 

Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee - 2015

Click here

 

The British Thyroid Association Guidelines for the Management of Thyroid Cancer 2014

Click here 

 

Armour Thyroid (USP) and combined thyroxine/tri-iodothyronine as Thyroid Hormone Replacement 2007

Click here

 

The UK Guidelines for the use of Thyroid Function Tests 2006

Click here 

 

 

Guidelines from other bodies

We are responsible for the development and production of guidelines in various thyroidology subject areas but in principle will endorse guidelines prepared by other societies.

Please click here to download our Guidelines Endorsement Statement 

 

 

Other useful guidelines

 

The Management of Patients with Graves' Orbitopathy - Clinical Medicine 2015

Click here

 

The diagnosis and management of primary hypothyroidism - Royal College of Physicians - Revised 2011

Click here

 

Guidelines from the American Thyroid Association

Click here

 

To download the clinical practice guidelines from the Endocrine Society

Click here

 

To download the clinical practice guidelines from the American Association of Clinical Endocrinologists

Click here

 

To download the British Fluoridation Statement on Thyroid Disorders and Fluoride (2006)

Click here